Pharmacotherapy for schizophrenia and co-occurring substance use disorders Douglas L. NoordsyAlan I. Green OriginalPaper Pages: 340 - 346
Neuroimaging in drug abuse Kimberly P. LindseyS. John GatleyNora D. Volkow OriginalPaper Pages: 355 - 361
Psychosocial treatments for cocaine dependence Grace O’Leary HennessyVictoria De MenilRoger D. Weiss OriginalPaper Pages: 362 - 364
The safety and efficacy of modafinil in multiple sclerosis-related fatigue Thomas W. McAllister Clinical Trials Report Pages: 367 - 367
The efficacy of donepezil in schizophrenic cognitive deficits Thomas W. McAllister Clinical Trials Report Pages: 367 - 368
Neuroimaging and neurocircuitry in post-traumatic stress disorder: What is currently known? Kaloyan Tanev OriginalPaper Pages: 369 - 383
Cognitive and neuropsychiatric aspects of subclinical hypothyroidism: Significance in the elderly Jennifer Duncan DavisRobert A. SternLaura A. Flashman OriginalPaper Pages: 384 - 390
The cholinergic hypothesis of cognitive impairment caused by traumatic brain injury David B. Arciniegas OriginalPaper Pages: 391 - 399
Genetic polymorphisms in the expression and treatment of neuropsychiatric disorders Thomas W. McAllisterLanier Summerall OriginalPaper Pages: 400 - 409
Complex partial seizures and depression Brian A. GreenleeRichard B. FerrellThomas W. McAllister OriginalPaper Pages: 410 - 416